Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$4000.0.

  • Tonix Pharmaceuticals Holding's Exchange Rate Effect rose 7647.06% to -$4000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7000.0, marking a year-over-year increase of 12333.33%. This contributed to the annual value of $4000.0 for FY2024, which is 10615.38% up from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Exchange Rate Effect stood at -$4000.0, which was up 7647.06% from -$4000.0 recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Exchange Rate Effect ranged from a high of $24000.0 in Q4 2024 and a low of -$43000.0 during Q1 2023
  • Its 3-year average for Exchange Rate Effect is -$7800.0, with a median of -$6500.0 in 2024.
  • Per our database at Business Quant, Tonix Pharmaceuticals Holding's Exchange Rate Effect skyrocketed by 34000.0% in 2024 and then crashed by 50000.0% in 2025.
  • Tonix Pharmaceuticals Holding's Exchange Rate Effect (Quarter) stood at -$10000.0 in 2023, then soared by 340.0% to $24000.0 in 2024, then plummeted by 116.67% to -$4000.0 in 2025.
  • Its last three reported values are -$4000.0 in Q3 2025, -$4000.0 for Q2 2025, and -$9000.0 during Q1 2025.